CEO of Crispr Therapeutics Ag (30-Year Financial, Insider Trades) Samarth Kulkarni (insider trades) sold 15,000 shares of CRSP on 05/20/2020 at an average price of $65.25 a share. The total sale was $978,750.
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR Therapeutics AG has a market cap of $4.14 billion; its shares were traded at around $67.78 with a P/E ratio of 90.37 and P/S ratio of 14.04. GuruFocus has detected 2 severe warning signs with CRISPR Therapeutics AG. .
CEO Recent Trades:
- CEO Samarth Kulkarni sold 15,000 shares of CRSP stock on 05/20/2020 at the average price of $65.25. The price of the stock has increased by 3.88% since.
Directors and Officers Recent Trades:
- President Rodger Novak sold 50,000 shares of CRSP stock on 05/19/2020 at the average price of $65. The price of the stock has increased by 4.28% since.
- CBO & COO Lawrence Otto Klein sold 25,000 shares of CRSP stock on 05/11/2020 at the average price of $60.4. The price of the stock has increased by 12.22% since.
For the complete insider trading history of CRSP, click here
.
